Caina Technology Co., Ltd.

Shenzhen Stock Exchange 301122.SZ

Caina Technology Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 5.52

Caina Technology Co., Ltd. Price to Sales Ratio (P/S) is 5.52 on January 14, 2025, a -41.64% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Caina Technology Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 9.47 on January 15, 2024, which is 71.34% above the current Price to Sales Ratio (P/S).
  • Caina Technology Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 4.44 on September 18, 2024, which is -19.61% below the current Price to Sales Ratio (P/S).
  • Caina Technology Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 6.37.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Shenzhen Stock Exchange: 301122.SZ

Caina Technology Co., Ltd.

CEO Mr. Jun Lu
IPO Date Jan. 26, 2022
Location China
Headquarters No. 23, Huaxi Road
Employees 689
Sector Health Care
Industries
Pharmaceuticals Biotechnology Medical Instruments
Description

Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. The company was founded in 2004 and is based in Jiangyin, China.

StockViz Staff

January 15, 2025

Any question? Send us an email